Literature DB >> 30959155

Performance of LC-MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome.

Andrea Oßwald1, Rong Wang2, Felix Beuschlein3, Michaela F Hartmann2, Stefan A Wudy2, Martin Bidlingmaier1, Stephanie Zopp1, Martin Reincke4, Katrin Ritzel1.   

Abstract

24-h urine free cortisol (UFC) is an indicator of integrated cortisol secretion and established screening tool for Cushing's syndrome (CS). Doubts have been raised regarding specificity of immunoassays, and mass spectrometric techniques have been proposed as an alternative. In the present study we compared diagnostic accuracy of UFC measured with LC-MS/MS vs. immunoassay in patient with CS and patients where CS has been excluded. We examined 24-h urine samples from patients with surgically confirmed CS (n = 77; Cushing's disease (n = 44), ectopic CS (n = 5), adrenal CS (n = 28)) and patients in whom Cushing's syndrome was excluded (n = 97) by long-term follow up. UFC was first measured by automated chemiluminescence immunoassays (ADVIA Centaur, Siemens; LIAISON, DiaSorin). Aliquots of all samples were also analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Statistics: Passing-Bablok Regression, Receiver operating characteristic (ROC) analysis with Youden's index calculation. UFC of CS patients were higher with both immunoassays compared to LC-MS/MS (913 +/- 235 vs. 303 +/- 155 μg/24 h (ADVIA) and 898 +/-216 vs. 399 +/- 196 μg/24 h (LIAISON)). Similarly, UFC were higher with immunoassays than with LC-MS/MS in the control group (223 +/- 10 vs. 23 +/- 2 μg/24 h (ADVIA) and 105 +/- 6 vs. 27 +/- 4 ug/24 h for (LIAISON)). Passing-Bablok regression showed good correlation between LC-MS/MS and ADVIA as well as between LCMS/MS and LIAISON (r = 0.96 and r = 0.99, p < 000.1) but less correlation in controls (r = 0.83 and r = 0.74, respectively, p < 000.1). ROC calculation revealed the highest ROC AUC (0.89) for the LIAISON immunoassay, followed by LC-MS/MS (0.82) and the ADVIA (0.80). In direct comparison, AUCs from LC-MS/MS and immunoassays in the same patient were not statistically different (p < 0,001). Best cut-off concentration to identify patients with CS was 234 μg/24 h (LIAISON), 51 μg/24 h for LC-MS/MS and 330 μg/24 h (ADVIA Centaur). In summary, UFC values were measured substantially higher by both immunoassays compared to LC-MS/MS. This is most likely due to cross-reactivity from interfering glucocorticoid metabolites. Nevertheless, all three methods correlated well. ROC analysis revealed the highest AUC for one of the immunoassays, although differences between the three methods were not significant. Direct comparison with LC-MS/MS indicates that high diagnostic accuracy can be obtained with suitable immunoassays.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Cushing’s syndrome; Immunoassay; LC–MS/MS; Urine free cortisol

Mesh:

Substances:

Year:  2019        PMID: 30959155     DOI: 10.1016/j.jsbmb.2019.04.004

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

Review 1.  Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Authors:  Lynnette K Nieman
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

2.  Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study.

Authors:  Leah T Braun; Stephanie Zopp; Frederick Vogel; Jürgen Honegger; German Rubinstein; Katharina Schilbach; Heike Künzel; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2021-04-19       Impact factor: 3.633

Review 3.  Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part I-Development.

Authors:  Brian A Rappold
Journal:  Ann Lab Med       Date:  2022-03-01       Impact factor: 3.464

4.  Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome.

Authors:  Arturo Vega-Beyhart; Javier Laguna-Moreno; Daniela Díaz-Catalán; Laura Boswell; Mireia Mora; Irene Halperin; Gregori Casals; Felicia A Hanzu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-23       Impact factor: 5.555

5.  Quantification of cortisol and its metabolites in human urine by LC-MSn: applications in clinical diagnosis and anti-doping control.

Authors:  Francesco Arioli; Maria Cristina Gamberini; Radmila Pavlovic; Federica Di Cesare; Susanna Draghi; Giulia Bussei; Francesca Mungiguerra; Alessio Casati; Marco Fidani
Journal:  Anal Bioanal Chem       Date:  2022-08-02       Impact factor: 4.478

Review 6.  Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?

Authors:  Gregori Casals; Felicia Alexandra Hanzu
Journal:  Ann Lab Med       Date:  2020-07       Impact factor: 3.464

7.  Neutrophil-Lymphocyte Ratio as an Initial Screening Biomarker for Differential Diagnosis of Cushing's Syndrome from Nonfunctional Adenoma in Patients with an Adrenal Mass.

Authors:  Wei Wang; Jianing Wang; Cheng Shen; Sainan Zhu; Ying Gao; Junqing Zhang
Journal:  Biomed Res Int       Date:  2021-02-15       Impact factor: 3.411

8.  Characteristics of preoperative steroid profiles and glucose metabolism in patients with primary aldosteronism developing adrenal insufficiency after adrenalectomy.

Authors:  Xiao Wang; Daniel A Heinrich; Sonja L Kunz; Nina Heger; Lisa Sturm; Olaf Uhl; Felix Beuschlein; Martin Reincke; Martin Bidlingmaier
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.